Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $36 | In Stock | |
5 mg | $54 | In Stock | |
10 mg | $77 | In Stock | |
25 mg | $123 | In Stock | |
50 mg | $179 | In Stock | |
100 mg | $266 | In Stock | |
200 mg | $395 | In Stock |
Description | Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research. |
In vitro | Tipiracil functions as a thymidine phosphorylase inhibitor, enhancing trifluridine's efficacy by impeding its metabolism via thymidine phosphorylase. This synergistic action facilitates the use of the Trifluridine-Tipiracil combination as an innovative oral treatment for metastatic colorectal cancer [2]. Additionally, Tipiracil fortifies the stability of FTD by mitigating its first-pass degradation through its inhibitory action on thymidine phosphorylase [3]. |
Molecular Weight | 242.66 |
Formula | C9H11ClN4O2 |
Cas No. | 183204-74-2 |
Color | White |
Appearance | Solid |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
Solubility Information | H2O: 0.8 mg/mL (3.3 mM), Sonication is recommended. DMSO: < 1 mg/mL (insoluble) | ||||||||||
Solution Preparation Table | |||||||||||
H2O
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.